Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies
about
Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysisMultimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis AblationFeasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastasesPercutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma.Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases.Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.Elevated Ki-67 labeling index in 'synchronous liver metastases' of well differentiated enteropancreatic neuroendocrine tumor.Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.Immediate Post-ablation FDG-injection and corresponding Standardized Uptake Value is a Surrogate Biomarker of Local Tumor Progression after Thermal Ablation of Colorectal Carcinoma Liver Metastases.Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.
P2860
Q26784351-6AB42723-2674-44B4-BEAA-2BF006A13D74Q30415023-FA0F84F7-05F2-4915-9E39-3EBFF077CEAAQ33835460-FAB665D3-E0BE-44A0-ACD6-EA504F88DCF4Q33865049-D19C0896-150A-4A1F-A4D4-7DE72383551DQ34003713-E684DDA5-2874-4BC0-9647-FBBD698E8AEAQ36524431-D799E274-D54C-4A5A-BED1-941BED016370Q36946481-2A54242C-6706-4523-8635-56C61F35AB6AQ38125094-C2743ADC-741F-465A-A272-95C83202B80FQ38412660-B61400A7-0709-43AD-8214-3544A2D1F4D2Q38726773-D9E41D76-3232-4145-A7AA-21BFFD534A69Q38787064-F301F917-E2C2-4D84-B866-889C450A85ACQ41548862-4855FD86-7895-4AA3-8583-24666EC83481Q41934918-05AF32FF-A510-4E07-948C-75C5668BD2A7Q42371613-F560BCFD-5AC0-4385-AB82-F552557E9A75Q43629579-9FADB604-C0C3-4FCD-99CC-FE64BCEE3417Q48301301-BC1FD86E-AEF0-4A94-A66A-3C951A09A27DQ50036604-EAE08BD7-7FFD-426D-9D4C-316AE0C12B40Q53084428-10EC04DC-58C3-40AC-B809-3C13F65CA540
P2860
Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@ast
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@en
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@nl
type
label
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@ast
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@en
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@nl
prefLabel
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@ast
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@en
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@nl
P2093
P2860
P1476
Ki-67 is a prognostic biomarke ...... ablation of liver malignancies
@en
P2093
Ann M Covey
Constantinos T Sofocleous
David S Klimstra
Elena N Petre
Lawrence Schwartz
Lydia M Petrovic
Lynn A Brody
Mithat Gonen
Nancy E Kemeny
Ronald P Dematteo
P2860
P2888
P304
P356
10.1245/S10434-012-2461-9
P577
2012-07-03T00:00:00Z
P6179
1024919655